Sun Pharma to acquire Organon in $11.75 bln all-cash deal

Organon & Co.

27/04/2026 24:59

April 26 (Reuters) - Sun Pharmaceutical Industries SUN.NS will acquire Organon & Co OGN.N in an all‑cash deal, valuing the U.S. drugmaker at about $11.75 billion, the companies said in a joint statement on Sunday.

 (Reporting by Mihika Sharma in Bengaluru; Editing by Subhranshu Sahu)

 ((Mihika.Sharma@thomsonreuters.com;))